{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:31:22Z","timestamp":1747153882596,"version":"3.40.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11926-020-00897-5","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T20:03:59Z","timestamp":1589486639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Does Belonging to a Patient Association Is of Help for Patients with Axial Spondyloarthritis? Results from the Atlas Survey"],"prefix":"10.1007","volume":"22","author":[{"name":"on behalf of the Atlas working group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9727-1189","authenticated-orcid":false,"given":"Marco","family":"Garrido-Cumbrera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4109-8991","authenticated-orcid":false,"given":"Jorge","family":"Chac\u00f3n-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4527-852X","authenticated-orcid":false,"given":"Victoria","family":"Navarro-Comp\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4007-4103","authenticated-orcid":false,"given":"Jordi","family":"Gratac\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6801-0836","authenticated-orcid":false,"given":"Sergio","family":"Sanz-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7647-6289","authenticated-orcid":false,"given":"Eduardo","family":"Collantes-Estevez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"key":"897_CR1","unstructured":"European Medicines Agency. Criteria for patient, consumer and healthcare professional organisations. London, 2018."},{"key":"897_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/00002281-200007000-00002","volume":"12","author":"E Feldtkeller","year":"2000","unstructured":"Feldtkeller E, Bruckel J, Khan MA. Scientific contributions of ankylosing spondylitis patient advocacy groups. Curr Opin Rheumatol. 2000;12:239\u201347.","journal-title":"Curr Opin Rheumatol"},{"key":"897_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40271-017-0216-1","volume":"10","author":"D Wong-Rieger","year":"2017","unstructured":"Wong-Rieger D. Moving from patient advocacy to partnership: a long and bumpy road. Patient. 2017;10:271\u20136.","journal-title":"Patient"},{"key":"897_CR4","volume-title":"Peer support groups by and for people with lived experience","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Peer support groups by and for people with lived experience. Geneva: WHO Quality Rights guidance module; 2019."},{"key":"897_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pec.2008.07.044","volume":"74","author":"CF van Uden-Kraan","year":"2009","unstructured":"van Uden-Kraan CF, Drossaert CHC, Taal E, Seydel ER, van de Laar MAFJ. Participation in online patient support groups endorses patients\u2019 empowerment. Patient Educ Couns. 2009;74:61\u20139.","journal-title":"Patient Educ Couns"},{"issue":"5","key":"897_CR6","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2217\/ijr.10.56","volume":"5","author":"Kate Hamilton-West","year":"2010","unstructured":"Hamilton-West K. Managing the impact of ankylosing spondylitis on the patient and society. Int J Clin Rheumatol. 2010:537\u201346.","journal-title":"International Journal of Clinical Rheumatology"},{"key":"897_CR7","doi-asserted-by":"crossref","unstructured":"Groves J. International Alliance of Patients\u2019 Organizations perspectives on person-centered medicine. Int J Integr Care. 2010.","DOI":"10.5750\/ijpcm.v1i3.96"},{"key":"897_CR8","doi-asserted-by":"crossref","unstructured":"No\u00ebl PH, Parchman ML, Palmer RF, Romero RL, Leykum LK, Lanham HJ, et al. Alignment of patient and primary care practice member perspectives of chronic illness care: a cross-sectional analysis. BMC Fam Pract. 2014;15:1\u20138.","DOI":"10.1186\/1471-2296-15-57"},{"key":"897_CR9","volume-title":"Chronic rheumatic conditions","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Chronic rheumatic conditions. Geneva: WHO; 2016."},{"key":"897_CR10","doi-asserted-by":"crossref","unstructured":"Senanayake S, Harrison K, Lewis M, Mcnarry M, Hudson J. Patients\u2019 experiences of coping with idiopathic pulmonary fibrosis and their recommendations for its clinical management. 1\u201314, 2018.","DOI":"10.1371\/journal.pone.0197660"},{"issue":"10089","key":"897_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","volume":"390","author":"Joachim Sieper","year":"2017","unstructured":"Sieper J, Poddubnyy D. Axial spondyloarthritis. Lancet. 2017;390:73\u201384.","journal-title":"The Lancet"},{"issue":"4","key":"897_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1136\/ard.2005.041137","volume":"65","author":"J Zochling","year":"2006","unstructured":"Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis JC Jr, Dijkmans B, et al. ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2006;65:442\u201352.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"897_CR13","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/ard.2008.096073","volume":"68","author":"U Kiltz","year":"2009","unstructured":"Kiltz U, van der Heijde D, Mielants H, Feldtkeller E, Braun J, PARE\/EULAR patient initiative group. ASAS\/EULAR recommendations for the management of ankylosing spondylitis: the patient version. Ann Rheum Dis. 2009;68:1381\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"897_CR14","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1136\/ard.2011.151027","volume":"70","author":"J Braun","year":"2011","unstructured":"Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, et al. 2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011;70:896\u2013904.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"897_CR15","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 van der Heijde D, Ramiro S, Landew\u00e9 R, Baraliakos X, van den Bosch F, Sepriano A, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76:978\u201391. This document presents the 2016 ASAS-EULAR recommendations for the management of patients with axSpA.","DOI":"10.1136\/annrheumdis-2016-210770"},{"key":"897_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/BF02207961","volume":"11","author":"JH Barlow","year":"1992","unstructured":"Barlow JH, Macey SJ, Struthers G. Psychosocial factors and self-help in ankylosing spondylitis patients. Clin Rheumatol. 1992;11:220\u20135.","journal-title":"Clin Rheumatol"},{"issue":"2-3","key":"897_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0738-3991(93)90129-K","volume":"20","author":"Julie H. Barlow","year":"1993","unstructured":"\u2022 Barlow JH, Macey SJ, Struthers GR. Health locus of control, self-help and treatment adherence in relation to ankylosing spondylitis patients. Patient Educ Couns. 1993;20:153\u201366.","journal-title":"Patient Education and Counseling"},{"issue":"3","key":"897_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jbspin.2015.06.012","volume":"83","author":"In-Ho Song","year":"2016","unstructured":"\u2022 Song I-H, Brenneis C, Hammel L, Feldtkeller E, Listing J, Sieper J, et al. Ankylosing spondylitis self-help organisations \u2013 do members differ from non-members? Jt Bone Spine. 2016;83:295\u2013300. This study is one of the few adressing health status of axSpA patients by their membership to a patient association.","journal-title":"Joint Bone Spine"},{"key":"897_CR19","unstructured":"\u2022 Garrido Cumbrera M, G\u00e1lvez Ruiz D, Chac\u00f3n Garc\u00eda J, et al. Atlas of axial spondyloarthritis in Spain 2017. Profile of the disease. Max Weber Institute, 2017. This article exposes in depth the methodology used for the Spanish Atlas 2017."},{"issue":"3","key":"897_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.reumae.2018.09.010","volume":"15","author":"Marco Garrido-Cumbrera","year":"2019","unstructured":"Garrido-Cumbrera M, Navarro-Comp\u00e1n V, Zarco P, Collantes-Est\u00e9vez E, G\u00e1lvez-Ruiz D, Bra\u00e7e O, et al. Atlas of axial spondyloarthritis in Spain 2017: study design and population. Reumatol Clin. 2019;15:127\u201332.","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"key":"897_CR21","doi-asserted-by":"crossref","unstructured":"\u2022 Higgins J, Green S. Cochrane handbook for systematic reviews of interventions: Cochrane Book Series Edited, 2008. This is the full report of the Spanish Atlas of Axial Spondyloarthritis 2017. It contains a complete and comprehensive description of the sample.","DOI":"10.1002\/9780470712184"},{"issue":"7","key":"897_CR22","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s00296-011-1932-9","volume":"32","author":"L. Altan","year":"2011","unstructured":"Altan L, Korkmaz N, Dizdar M, Yurtkuran M. Effect of pilates training on people with ankylosing spondylitis. Rheumatol Int. 2012;32:2093\u20139.","journal-title":"Rheumatology International"},{"key":"897_CR23","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00296-013-2869-y","volume":"34","author":"MO Ro\u015fu","year":"2014","unstructured":"Ro\u015fu MO, \u0162opa I, Chirieac R, Ancuta C. Effects of pilates, McKenzie and Heckscher training on disease activity, spinal motility and pulmonary function in patients with ankylosing spondylitis: a randomized controlled trial. Rheumatol Int. 2014;34:367\u201372.","journal-title":"Rheumatol Int"},{"key":"897_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.4103\/0975-9476.72619","volume":"1","author":"M Edavalath","year":"2010","unstructured":"Edavalath M. Ankylosing spondylitis. J Ayurveda Integr Med. 2010;1:211\u20134.","journal-title":"J Ayurveda Integr Med"},{"key":"897_CR25","doi-asserted-by":"crossref","unstructured":"Dundar U, Solak O, Toktas H, Demirdal US, Subasi V, Kavuncu V, Evcik D. Effect of aquatic exercise on ankylosing spondylitis: a randomized controlled trial. Rheumatol Int 1\u20137, 2014.","DOI":"10.1007\/s00296-014-2980-8"},{"key":"897_CR26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0889-857X(21)00915-7","volume":"16","author":"RL McNeal","year":"1990","unstructured":"McNeal RL. Aquatic therapy for patients with rheumatic disease. Rheum Dis Clin N Am. 1990;16:915\u201329.","journal-title":"Rheum Dis Clin N Am"},{"key":"897_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/ecam\/nem048","volume":"5","author":"E Lee","year":"2008","unstructured":"Lee E, Kim Y, Chung WT, Lee MS. Tai chi for disease activity and flexibility in patients with ankylosing spondylitis--a controlled clinical trial. Evid Based Complement Alternat Med. 2008;5:457\u201362.","journal-title":"Evid Based Complement Alternat Med"},{"key":"897_CR28","first-page":"372","volume":"31","author":"R Ariza-Ariza","year":"2004","unstructured":"Ariza-Ariza R, Hern\u00e1ndez-Cruz B, Navarro-Sarabia F. La versi\u00f3n espa\u00f1ola del BASDAI es fiable y se correlaciona con la actividad de la enfermedad en pacientes con espondilitis anquilosante. Rev Esp Reumatol. 2004;31:372\u20138.","journal-title":"Rev Esp Reumatol"},{"key":"897_CR29","first-page":"988","volume":"26","author":"A Calin","year":"1999","unstructured":"Calin A, Mackay K, Santos H, Brophy S. A new dimension to outcome: application of the Bath Ankylosing Spondylitis Radiology Index. J Rheumatol. 1999;26:988\u201392.","journal-title":"J Rheumatol"},{"key":"897_CR30","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21:2286\u201391.","journal-title":"J Rheumatol"},{"issue":"1","key":"897_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1017\/S0033291796004242","volume":"27","author":"D. P. GOLDBERG","year":"1997","unstructured":"Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997;27:191\u20137.","journal-title":"Psychological Medicine"},{"key":"897_CR32","unstructured":"Goldberg D, Williams P. A user\u2019s guide to the General Health Questionnaire. UK, 1988."},{"key":"897_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1017\/S0033291700050972","volume":"13","author":"MH Banks","year":"1983","unstructured":"Banks MH. Validation of the General Health Questionnaire in a young community sample. Psychol Med. 1983;13:349\u201353.","journal-title":"Psychol Med"},{"key":"897_CR34","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00296-013-2727-y","volume":"33","author":"E Feldtkeller","year":"2013","unstructured":"Feldtkeller E, Lind-Albrecht G, Rudwaleit M. Core set of recommendations for patients with ankylosing spondylitis concerning behaviour and environmental adaptations. Rheumatol Int. 2013;33:2343\u20139.","journal-title":"Rheumatol Int"},{"key":"897_CR35","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.3899\/jrheum.110641","volume":"38","author":"DL Mattet","year":"2011","unstructured":"Mattet DL, Dawson SR, Healey EL, Packman JC. Relationship between smoking and patient-reported measures of disease outcome in ankylosing spondylitis. J Rheumatol. 2011;38:2608\u201315.","journal-title":"J Rheumatol"},{"key":"897_CR36","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/annrheumdis-2011-200180","volume":"71","author":"HY Chung","year":"2012","unstructured":"Chung HY, Machado P, Van Der Heijde D, Agostino MD, Dougados M. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis. 2012;71:809\u201316.","journal-title":"Ann Rheum Dis"},{"key":"897_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/03009749609080003","volume":"25","author":"HL Averns","year":"1996","unstructured":"Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT. Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol. 1996;25:138\u201342.","journal-title":"Scand J Rheumatol"},{"key":"897_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00296-004-0451-3","volume":"25","author":"U Kaan","year":"2005","unstructured":"Kaan U, Ferda \u00d6. Evaluation of clinical activity and functional impairment in smokers with ankylosing spondylitis. Rheumatol Int. 2005;25:357\u201360.","journal-title":"Rheumatol Int"},{"issue":"4","key":"897_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11136-010-9771-9","volume":"20","author":"Hatice Bodur","year":"2010","unstructured":"Bodur H, Ataman \u015e, Rezvani A, Bu\u011fdayc\u0131 DS, Cevik R, Birtane M, et al. Quality of life and related variables in patients with ankylosing spondylitis. Qual Life Res. 2011;20:543\u20139.","journal-title":"Quality of Life Research"},{"key":"897_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/1529-0131(200201)46:1<223::AID-ART498>3.0.CO;2-#","volume":"46","author":"MM Ward","year":"2002","unstructured":"Ward MM. Functional disability predicts total costs in patients with ankylosing spondylitis. Arthritis Rheum. 2002;46:223\u201331.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"897_CR41","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1136\/ard.60.11.1033","volume":"60","author":"A Boonen","year":"2001","unstructured":"Boonen A, Chorus A, Miedema H, Van Der Heijde D, Landew\u00e9 R, Schouten H, et al. Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Ann Rheum Dis. 2001;60:1033\u20139.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"897_CR42","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1111\/1756-185X.12306","volume":"20","author":"A Abdul-Sattar","year":"2017","unstructured":"Abdul-Sattar A, Abou El Magd S. Prevalence and associated risk factors for work disability in Egyptian patients with ankylosing spondylitis from one center. Int J Rheum Dis. 2017;20:2028\u201334.","journal-title":"Int J Rheum Dis"},{"key":"897_CR43","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing spondylitis functional index. J Rheumatol. 1994;21."},{"key":"897_CR44","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/ard.2003.016386","volume":"63","author":"M Rudwaleit","year":"2004","unstructured":"Rudwaleit M, Listing J, Brandt J, Braun J, Sieper J. Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis. 2004;63:665\u201370.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"897_CR45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","volume":"45","author":"C.-H. Chen","year":"2005","unstructured":"Chen C-H, Lin K-C, Yu DTY, Yang C, Huang F, Chen HA, et al. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology. 2006;45:414\u201320.","journal-title":"Rheumatology"},{"key":"897_CR46","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/ard.2008.091793","volume":"68","author":"R Landew\u00e9","year":"2009","unstructured":"Landew\u00e9 R, Dougados M, Mielants H, van der Tempel H, van der Heijde D. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine. Ann Rheum Dis. 2009;68:863\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"897_CR47","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A","volume":"44","author":"J. Hamersma","year":"2001","unstructured":"Hamersma J, Cardon LR, Bradbury L, Brophy S, Van Der Horst-Bruinsma I, Calin A, et al. Is disease severity in ankylosing spondylitis genetically determined? Arthritis Rheum. 2001;44:1396\u2013400.","journal-title":"Arthritis & Rheumatism"},{"key":"897_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2196\/jmir.1625","volume":"13","author":"CF Van Uden-Kraan","year":"2011","unstructured":"Van Uden-Kraan CF, Drossaert CHC, Taal E, Smit WM, Bernelot Moens HJ, Van de Laar MAFJ. Determinants of engagement in face-to-face and online patient support groups. J Med Internet Res. 2011;13:1\u201311.","journal-title":"J Med Internet Res"},{"key":"897_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1053\/berh.2002.0242","volume":"16","author":"E Feldtkeller","year":"2002","unstructured":"Feldtkeller E. Do patient self-help organizations help? Best Pract Res Clin Rheumatol. 2002;16:667\u201373.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"897_CR50","doi-asserted-by":"crossref","unstructured":"Ji X, Hu L, Wang Y, Luo Y, Zhu J, Zhang J, et al. \u201cMobile health\u201d for the management of spondyloarthritis and its application in China. Curr Rheumatol Rep. 2019;21:1\u20136.","DOI":"10.1007\/s11926-019-0860-7"},{"key":"897_CR51","first-page":"281","volume-title":"Axial spondyloarthritis","author":"CV Caballero-Uribe","year":"2020","unstructured":"Caballero-Uribe CV, Khan MA. Patient education and patient service organizations. In: Mease P, Khan MA, editors. Axial spondyloarthritis. Amsterdam ISBN: 978\u20130-323:56800\u20135: Elsevier; 2020. p. 281\u20136."}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00897-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-020-00897-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-020-00897-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T19:25:17Z","timestamp":1666553117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-020-00897-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1007\/s11926-020-00897-5","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"type":"print","value":"1523-3774"},{"type":"electronic","value":"1534-6307"}],"subject":[],"published":{"date-parts":[[2020,5,14]]},"assertion":[{"value":"14 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Victoria Navarro-Comp\u00e1n has received unrelated honoraria or research grants from Abbvie, BMS, Lilly, MSD, Novartis, Pfizer, Roche, and UCB. Dr. Jordi Gratac\u00f3s has received unrelated honoraria or research grants from Abbvie, BMS, Lilly, MSD, Novartis, Pfizer, Roche, and UCB. Dr. Eduardo Collantes has received unrelated honoraria or research grants from Abbvie, BMS, Lilly, MSD, Novartis, Pfizer, Roche, and UCB. Other authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All patients agreed to their participation through informed consent. In this study, no clinical trial was conducted. As it was not an interventional study, no ethics committee approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"22"}}